Teligent, Inc. (TLGT)
Price:
0.17 USD
( - -0.03 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Intra-Cellular Therapies, Inc.
VALUE SCORE:
0
2nd position
Amphastar Pharmaceuticals, Inc.
VALUE SCORE:
11
The best
Lantheus Holdings, Inc.
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.
NEWS
TLGT Stock: Why The Price Substantially Fell
pulse2.com
2021-10-15 07:13:54The stock price of Teligent Inc (NASDAQ: TLGT) fell over 39% yesterday. This is why it happened.
Top Penny Stocks to Buy Right Now? 3 to Check Out This Month
pennystocks.com
2021-09-19 14:00:00Are these top penny stocks to watch on your list in September? The post Top Penny Stocks to Buy Right Now?
Teligent, Inc. (TLGT) CEO Tim Sawyer on Q2 2021 Results - Earnings Call Transcript
seekingalpha.com
2021-08-16 11:08:06Teligent, Inc. (TLGT) CEO Tim Sawyer on Q2 2021 Results - Earnings Call Transcript
Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update
globenewswire.com
2021-08-16 07:00:00BUENA, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the second quarter of 2021 and provided a business update.
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
globenewswire.com
2021-06-18 11:00:00Scheduled to Reconvene on June 30, 2021 Company Urgently Encourages Stockholders to Vote
Trading Biotech Penny Stocks? Check These 3 Out
pennystocks.com
2021-06-02 09:03:41Biotech penny stocks are heating up as Covid cases decline; which small-caps are on your watchlist? The post Trading Biotech Penny Stocks?
Teligent's (TLGT) CEO Tim Sawyer on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com
2021-05-25 14:12:03Teligent's (TLGT) CEO Tim Sawyer on Q1 2021 Results - Earnings Call Transcript
Teligent: Q1 Earnings Insights
benzinga.com
2021-05-25 07:32:31Shares of Teligent (NASDAQ:TLGT) rose 1.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 13.04% year over year to ($0.26), which may not compare to the estimate of ($2.11).
Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financial Results on Tuesday May 25, 2020
globenewswire.com
2021-05-21 16:30:00BUENA, N.J., May 21, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a conference call at 8:30AM ET on Tuesday, May 25th, 2021 to discuss the first quarter ended March 31, 2021 financial results and business update.
Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update
globenewswire.com
2021-05-03 18:45:00BUENA, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the fourth quarter and year ended December 31, 2020.
Teligent, Inc. Announces Appointment of William S. Marth to Board of Directors
prnewswire.com
2021-02-16 07:30:00BUENA, N.J., Feb. 16, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed industry veteran William S. Marth to its Board of Directors, effective immediately. Mr....
Teligent Regains Compliance with Nasdaq Filing Requirements and Nasdaq Minimum Market Value Rule
globenewswire.com
2021-01-22 09:00:00BUENA, N.J., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, previously received notice from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the Company not having timely filed its Quarterly Report on Form 10-Q for the three months ended September 30, 2020 (the “Form 10-Q”) with the Securities and Exchange Commission. Upon filing of the Form 10-Q on December 31, 2020, the Company regained compliance with Nasdaq Listing Rule 5250(c)(1) and this matter is now closed.
Teligent, Inc. Announces Third Quarter 2020 Results
globenewswire.com
2020-12-31 15:21:00BUENA, N.J., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter ended September 30, 2020.
Teligent: 7 Things for Investors to Know About TLGT Stock
investorplace.com
2020-12-14 12:21:27Shares of TLGT stock are soaring on Monday ahead of a special shareholder vote to address Teligent's Nasdaq compliance. The post Teligent: 7 Things for Investors to Know About TLGT Stock appeared first on InvestorPlace.
Why Is It Moving? Analyzing The Upward Movement in Teligent's Stock Today
benzinga.com
2020-12-14 10:01:43Teligent (NASDAQ: TLGT) is currently up 67.3% to a price of $1.12. Monday the stock has been traded at a volume of 36.45 million, about 851.24% of its recent 30-day volume average of 4.28 million.
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
globenewswire.com
2020-11-25 12:00:00Scheduled to Reconvene on December 16 , 2020 Company Urgently Encourages Stockholders to Vote
TLGT Stock: Why The Price Substantially Fell
pulse2.com
2021-10-15 07:13:54The stock price of Teligent Inc (NASDAQ: TLGT) fell over 39% yesterday. This is why it happened.
Top Penny Stocks to Buy Right Now? 3 to Check Out This Month
pennystocks.com
2021-09-19 14:00:00Are these top penny stocks to watch on your list in September? The post Top Penny Stocks to Buy Right Now?
Teligent, Inc. (TLGT) CEO Tim Sawyer on Q2 2021 Results - Earnings Call Transcript
seekingalpha.com
2021-08-16 11:08:06Teligent, Inc. (TLGT) CEO Tim Sawyer on Q2 2021 Results - Earnings Call Transcript
Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update
globenewswire.com
2021-08-16 07:00:00BUENA, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the second quarter of 2021 and provided a business update.
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
globenewswire.com
2021-06-18 11:00:00Scheduled to Reconvene on June 30, 2021 Company Urgently Encourages Stockholders to Vote
Trading Biotech Penny Stocks? Check These 3 Out
pennystocks.com
2021-06-02 09:03:41Biotech penny stocks are heating up as Covid cases decline; which small-caps are on your watchlist? The post Trading Biotech Penny Stocks?
Teligent's (TLGT) CEO Tim Sawyer on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com
2021-05-25 14:12:03Teligent's (TLGT) CEO Tim Sawyer on Q1 2021 Results - Earnings Call Transcript
Teligent: Q1 Earnings Insights
benzinga.com
2021-05-25 07:32:31Shares of Teligent (NASDAQ:TLGT) rose 1.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 13.04% year over year to ($0.26), which may not compare to the estimate of ($2.11).
Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financial Results on Tuesday May 25, 2020
globenewswire.com
2021-05-21 16:30:00BUENA, N.J., May 21, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a conference call at 8:30AM ET on Tuesday, May 25th, 2021 to discuss the first quarter ended March 31, 2021 financial results and business update.
Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update
globenewswire.com
2021-05-03 18:45:00BUENA, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the fourth quarter and year ended December 31, 2020.
Teligent, Inc. Announces Appointment of William S. Marth to Board of Directors
prnewswire.com
2021-02-16 07:30:00BUENA, N.J., Feb. 16, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed industry veteran William S. Marth to its Board of Directors, effective immediately. Mr....
Teligent Regains Compliance with Nasdaq Filing Requirements and Nasdaq Minimum Market Value Rule
globenewswire.com
2021-01-22 09:00:00BUENA, N.J., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, previously received notice from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the Company not having timely filed its Quarterly Report on Form 10-Q for the three months ended September 30, 2020 (the “Form 10-Q”) with the Securities and Exchange Commission. Upon filing of the Form 10-Q on December 31, 2020, the Company regained compliance with Nasdaq Listing Rule 5250(c)(1) and this matter is now closed.
Teligent, Inc. Announces Third Quarter 2020 Results
globenewswire.com
2020-12-31 15:21:00BUENA, N.J., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter ended September 30, 2020.
Teligent: 7 Things for Investors to Know About TLGT Stock
investorplace.com
2020-12-14 12:21:27Shares of TLGT stock are soaring on Monday ahead of a special shareholder vote to address Teligent's Nasdaq compliance. The post Teligent: 7 Things for Investors to Know About TLGT Stock appeared first on InvestorPlace.
Why Is It Moving? Analyzing The Upward Movement in Teligent's Stock Today
benzinga.com
2020-12-14 10:01:43Teligent (NASDAQ: TLGT) is currently up 67.3% to a price of $1.12. Monday the stock has been traded at a volume of 36.45 million, about 851.24% of its recent 30-day volume average of 4.28 million.
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
globenewswire.com
2020-11-25 12:00:00Scheduled to Reconvene on December 16 , 2020 Company Urgently Encourages Stockholders to Vote